Reg-Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® Ld/Hd in Europe
Reg-Alvotech和Advanz Pharma簽署歐洲Eylea® Ld/Hd生物類似物的商業化協議
Reg-Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® Ld/Hd in Europe
Reg-Alvotech和Advanz Pharma簽署歐洲Eylea® Ld/Hd生物類似物的商業化協議
譯文內容由第三人軟體翻譯。